Th1 polarization defines the synovial fluid T cell compartment in oligoarticular juvenile idiopathic arthritis.


Journal

JCI insight
ISSN: 2379-3708
Titre abrégé: JCI Insight
Pays: United States
ID NLM: 101676073

Informations de publication

Date de publication:
22 09 2021
Historique:
received: 02 03 2021
accepted: 11 08 2021
pubmed: 18 8 2021
medline: 17 3 2022
entrez: 17 8 2021
Statut: epublish

Résumé

Oligoarticular juvenile idiopathic arthritis (oligo JIA) is the most common form of chronic inflammatory arthritis in children, yet the cause of this disease remains unknown. To understand immune responses in oligo JIA, we immunophenotyped synovial fluid T cells with flow cytometry, bulk RNA-Seq, single-cell RNA-Seq (scRNA-Seq), DNA methylation studies, and Treg suppression assays. In synovial fluid, CD4+, CD8+, and γδ T cells expressed Th1-related markers, whereas Th17 cells were not enriched. Th1 skewing was prominent in CD4+ T cells, including Tregs, and was associated with severe disease. Transcriptomic studies confirmed a Th1 signature in CD4+ T cells from synovial fluid. The regulatory gene expression signature was preserved in Tregs, even those exhibiting Th1 polarization. These Th1-like Tregs maintained Treg-specific methylation patterns and suppressive function, supporting the stability of this Treg population in the joint. Although synovial fluid CD4+ T cells displayed an overall Th1 phenotype, scRNA-Seq uncovered heterogeneous effector and regulatory subpopulations, including IFN-induced Tregs, peripheral helper T cells, and cytotoxic CD4+ T cells. In conclusion, oligo JIA is characterized by Th1 polarization that encompasses Tregs but does not compromise their regulatory identity. Targeting Th1-driven inflammation and augmenting Treg function may represent important therapeutic approaches in oligo JIA.

Identifiants

pubmed: 34403374
pii: e149185
doi: 10.1172/jci.insight.149185
pmc: PMC8492302
doi:
pii:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NIAMS NIH HHS
ID : K08 AR073339
Pays : United States
Organisme : NHLBI NIH HHS
ID : T32 HL007633
Pays : United States
Organisme : NIAMS NIH HHS
ID : R01 AR073201
Pays : United States
Organisme : NIAMS NIH HHS
ID : P30 AR070253
Pays : United States
Organisme : NIAID NIH HHS
ID : T32 AI007512
Pays : United States
Organisme : NIAMS NIH HHS
ID : K08 AR077037
Pays : United States
Organisme : NIAMS NIH HHS
ID : R01 AR075906
Pays : United States

Références

J Rheumatol. 2004 Feb;31(2):390-2
pubmed: 14760812
J Rheumatol. 2009 Sep;36(9):2017-24
pubmed: 19648312
Nat Methods. 2013 Nov;10(11):1096-8
pubmed: 24056875
Arthritis Rheum. 2007 Feb;56(2):647-57
pubmed: 17265500
J Rheumatol. 2012 Oct;39(10):2021-31
pubmed: 22896021
Nat Immunol. 2015 Nov;16(11):1162-73
pubmed: 26437242
J Immunol. 2013 Mar 1;190(5):2001-8
pubmed: 23359504
J Immunol. 2014 Sep 15;193(6):2699-708
pubmed: 25092890
Bioinformatics. 2014 Apr 1;30(7):923-30
pubmed: 24227677
Cell Rep. 2019 Dec 3;29(10):3019-3032.e6
pubmed: 31801070
Proc Natl Acad Sci U S A. 2014 Mar 25;111(12):E1111-20
pubmed: 24610777
Front Immunol. 2018 Jul 10;9:1444
pubmed: 30061879
J Immunol. 2017 Mar 15;198(6):2249-2259
pubmed: 28167631
J Exp Med. 2006 Jul 10;203(7):1693-700
pubmed: 16818676
J Immunol. 2004 May 15;172(10):6435-43
pubmed: 15128835
Proc Natl Acad Sci U S A. 2010 Aug 17;107(33):14751-6
pubmed: 20679229
Nature. 2017 Jun 15;546(7658):421-425
pubmed: 28607488
Arthritis Rheum. 2000 Aug;43(8):1858-65
pubmed: 10943877
OMICS. 2012 May;16(5):284-7
pubmed: 22455463
J Immunol. 2002 Jun 1;168(11):5954-8
pubmed: 12023402
Genome Biol. 2014;15(12):550
pubmed: 25516281
Front Immunol. 2019 Mar 14;10:450
pubmed: 30930898
Semin Arthritis Rheum. 1996 Dec;26(3):575-91
pubmed: 8989803
Blood. 2011 Sep 29;118(13):3538-48
pubmed: 21828127
Arthritis Rheum. 2011 Oct;63(10):3153-62
pubmed: 21702013
Cell. 2020 Nov 25;183(5):1340-1353.e16
pubmed: 33096020
J Immunol. 2015 Sep 1;195(5):2030-7
pubmed: 26223658
Arthritis Rheum. 2000 Apr;43(4):765-74
pubmed: 10765921
Nature. 2010 Feb 11;463(7282):808-12
pubmed: 20072126
Arthritis Rheumatol. 2016 Jan;68(1):229-36
pubmed: 26360332
J Immunol. 2015 Dec 15;195(12):5616-24
pubmed: 26561546
Nature. 2017 Feb 1;542(7639):110-114
pubmed: 28150777
Cell. 2012 Sep 28;151(1):153-66
pubmed: 23021222
J Exp Med. 2007 Aug 6;204(8):1849-61
pubmed: 17635957
JCI Insight. 2020 Mar 26;5(6):
pubmed: 32213704
Arthritis Rheum. 2011 Nov;63(11):3467-76
pubmed: 21739422
Immunity. 2007 Nov;27(5):786-800
pubmed: 18024188
Front Immunol. 2017 Mar 06;8:103
pubmed: 28321213
Arthritis Rheum. 2008 Mar;58(3):875-87
pubmed: 18311821
Nucleic Acids Res. 2020 Jan 8;48(D1):D498-D503
pubmed: 31691815
Nat Immunol. 2009 Jun;10(6):595-602
pubmed: 19412181
J Immunol. 2006 Apr 15;176(8):4622-31
pubmed: 16585553
Clin Immunol. 2020 Aug;217:108484
pubmed: 32485239
J Immunol. 2008 Dec 15;181(12):8568-75
pubmed: 19050276
Front Immunol. 2017 Feb 23;8:194
pubmed: 28280496
Ann Rheum Dis. 2017 Feb;76(2):435-441
pubmed: 27311837
Ann Rheum Dis. 2016 Apr;76(4):765-772
pubmed: 27998952
Immunity. 2012 Sep 21;37(3):501-10
pubmed: 22960221
Clin Exp Immunol. 1997 Jul;109(1):4-11
pubmed: 9218817
Blood. 2013 Apr 4;121(14):2647-58
pubmed: 23355538
Bioinformatics. 2013 Jan 1;29(1):15-21
pubmed: 23104886
Cell Rep. 2014 Nov 6;9(3):1075-88
pubmed: 25437561
Cell. 2019 Jun 13;177(7):1888-1902.e21
pubmed: 31178118
Nat Immunol. 2018 Mar;19(3):291-301
pubmed: 29434354
Arthritis Rheum. 2011 Aug;63(8):2504-15
pubmed: 21381000
Genome Biol. 2018 Dec 19;19(1):224
pubmed: 30567574
Arthritis Rheumatol. 2018 Jan;70(1):7-17
pubmed: 29024575
J Rheumatol. 2009 Aug;36(8):1730-6
pubmed: 19531753
J Transl Med. 2009 Oct 22;7:89
pubmed: 19849846
Nat Methods. 2017 Apr;14(4):417-419
pubmed: 28263959
J Immunol. 2010 Apr 1;184(7):3433-41
pubmed: 20181882
J Exp Med. 2008 Aug 4;205(8):1903-16
pubmed: 18663128
Cell. 2017 Jun 1;169(6):1130-1141.e11
pubmed: 28552348
Nat Commun. 2017 Jan 16;8:14049
pubmed: 28091601
Blood. 2012 May 10;119(19):4430-40
pubmed: 22438251
Arthritis Rheumatol. 2016 Jul;68(7):1758-68
pubmed: 26815131
J Immunol. 2015 Apr 1;194(7):3116-26
pubmed: 25740946
Nat Med. 2011 Jul 24;17(8):975-82
pubmed: 21785433
Annu Rev Immunol. 2014;32:513-45
pubmed: 24555472
J Immunol. 2018 Jan 1;200(1):336-346
pubmed: 29180490
Nat Immunol. 2020 Sep;21(9):1107-1118
pubmed: 32788748

Auteurs

Amélie M Julé (AM)

Division of Immunology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.

Kacie J Hoyt (KJ)

Division of Immunology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.

Kevin Wei (K)

Division of Rheumatology, Inflammation, and Immunity, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.

Maria Gutierrez-Arcelus (M)

Division of Immunology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Division of Rheumatology, Inflammation, and Immunity, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.

Maria L Taylor (ML)

Division of Immunology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.

Julie Ng (J)

Division of Pulmonary and Critical Care Medicine, and.

James A Lederer (JA)

Department of Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.

Siobhan M Case (SM)

Division of Immunology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Division of Rheumatology, Inflammation, and Immunity, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.

Margaret H Chang (MH)

Division of Immunology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Division of Rheumatology, Inflammation, and Immunity, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.

Ezra M Cohen (EM)

Division of Immunology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.

Fatma Dedeoglu (F)

Division of Immunology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.

Melissa M Hazen (MM)

Division of Immunology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.

Jonathan S Hausmann (JS)

Division of Immunology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.

Olha Halyabar (O)

Division of Immunology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.

Erin Janssen (E)

Division of Immunology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.

Jeffrey Lo (J)

Division of Immunology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.

Mindy S Lo (MS)

Division of Immunology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.

Esra Meidan (E)

Division of Immunology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.

Jordan E Roberts (JE)

Division of Immunology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.

Mary Beth F Son (MBF)

Division of Immunology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.

Robert P Sundel (RP)

Division of Immunology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.

Pui Y Lee (PY)

Division of Immunology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Division of Rheumatology, Inflammation, and Immunity, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.

Talal Chatila (T)

Division of Immunology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.

Peter A Nigrovic (PA)

Division of Immunology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Division of Rheumatology, Inflammation, and Immunity, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.

Lauren A Henderson (LA)

Division of Immunology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH